MGMT and central nervous system cancer: High angiogenesis pathway score gliomas demonstrated a predilection for aggressive clinicopathological characteristics, such as higher grade, IDH wildtype genotype, 1p19q non-codeletion, MGMT promoter unmethylated status, and mesenchymal subtype.